Latest Lectin Stories
-- Phase 2 Clinical Trial Planned to Begin This Quarter -- SEATTLE, April 3, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that its Investigational New Drug
-- Phase 2 Program Expected to Initiate this Quarter -- SEATTLE, Feb.
A new technique based on atomic force microscopy was developed at the Institute of Food Research to help ‘read’ information encoded in the gut lining.
Researchers from Aarhus University, Denmark, have now discovered an important mechanism behind one of our most fundamental lines of immune function.
University of Utah researchers have discovered a new class of compounds that stick to the sugary coating of the AIDS virus and inhibit it from infecting cells – an early step toward a new treatment to prevent sexual transmission of the virus.
Stem cells show great potential to enable treatments for conditions such as spinal injuries or Lou Gehrig's disease, and also as research tools.
- Withering but not falling off, as a blossom that persists on a twig after flowering.